Tag: Revenue

Dollar Steady as Market Anticipates Fewer Rate Cuts Today market analysis on behalf of Bas Kooijman is the CEO and Asset Manager of DHF Capital S.A The U.S. dollar steadied following two consecutive sessions of declines. Market participants are reevaluating their positions after an extensive rally since early October, driven by political developments surrounding the U.S. election and, more recently, President-elect Donald Trump’s cabinet appointments. These developments are...

Top 20 Global Biopharma Companies See 2% Growth The biopharmaceutical industry demonstrated signs of recovery in the third quarter (Q3) of 2024, with increased investor optimism following the interest rate cuts by the US Federal Reserve in September 2024. As a result, the top 20 global biopharmaceutical companies reported an upturn of 2% in aggregate market capitalization from $4.2 trillion as on 30 June 2024...